Clinical Trial Update: Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating dapagliflozin's effects on inflammatory markers, erythropoiesis, and iron metabolism in people with type 2 diabetes and chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Assiut University | Conditions: Chronic Kidney Diseases, Diabetes Type 2 | Phase 3 | Status: NOT_YET_RECRUITING